CPIM
BMY icon

Columbia Partners Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Columbia Partners Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-33,365
Closed -$2.11M – 156
2018
Q1 		$2.11M Sell
33,365
-812
-2% -$52.2K 0.27% 110
2017
Q4 		$2.09M Sell
34,177
-33,605
-50% -$2.1M 0.28% 112
2017
Q3 		$4.32M Sell
67,782
-11,415
-14% -$667K 0.57% 49
2017
Q2 		$4.41M Buy
79,197
+18,208
+30% +$991K 0.56% 51
2017
Q1 		$3.32M Sell
60,989
-8,909
-13% -$489K 0.42% 74
2016
Q4 		$4.08M Sell
69,898
-31,097
-31% -$1.7M 0.36% 102
2016
Q3 		$5.45M Sell
100,995
-33,699
-25% -$2.16M 0.43% 84
2016
Q2 		$9.91M Sell
134,694
-28,864
-18% -$2.04M 0.74% 28
2016
Q1 		$10.4M Buy
163,558
+31,056
+23% +$1.96M 0.74% 27
2015
Q4 		$9.11M Buy
132,502
+467
+0.4% +$30.9K 0.63% 50
2015
Q3 		$7.82M Sell
132,035
-2,903
-2% -$184K 0.55% 68
2015
Q2 		$8.98M Sell
134,938
-32,925
-20% -$2.17M 0.55% 69
2015
Q1 		$10.8M Sell
167,863
-62,029
-27% -$3.88M 0.58% 63
2014
Q4 		$13.6M Sell
229,892
-12,624
-5% -$712K 0.7% 36
2014
Q3 		$12.4M Buy
242,516
+23,261
+11% +$1.16M 0.63% 44
2014
Q2 		$10.6M Sell
219,255
-12,926
-6% -$637K 0.49% 67
2014
Q1 		$12.1M Buy
232,181
+44,727
+24% +$2.38M 0.53% 57
2013
Q4 		$9.96M Buy
187,454
+11,634
+7% +$593K 0.43% 80
2013
Q3 		$8.14M Buy
175,820
+6,489
+4% +$285K 0.36% 103
2013
Q2 		$7.57M Buy
+169,331
New +$7.35M 0.36% 103

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Columbia Partners Investment Management's BMY Position: Q2 2018 in Review

Columbia Partners Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 33,365 shares — an estimated $2.11M sold.

Columbia Partners Investment Management first reported a position in BMY in Q2 2013 and held it in 20 quarters. The position peaked at $13.6M in Q4 2014. 1,692 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

  • Columbia Partners Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
  • Columbia Partners Investment Management sold 33,365 Bristol-Myers Squibb shares in Q2 2018, an estimated $2.11M.
  • Columbia Partners Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 20 quarters.
  • Columbia Partners Investment Management's Bristol-Myers Squibb position peaked at $13.6M in Q4 2014.
  • 1,692 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Columbia Partners Investment Management's 13F filing for Q2 2018, filed 12 Jul 2018.